NextRNA Therapeutics Inc.

https://www.nextrnatx.com

LinkedIn: https://www.linkedin.com/company/nextrna-therapeutics

NextRNA is a biotechnology company focused on developing transformative medicines to address long non-coding RNA (lncRNA)-driven diseases, with a primary focus on oncology and neuroscience. Dysregulated lncRNAs recruit RNA-binding proteins (RBPs) to drive pathological processes across disease areas. Our therapeutic approach centers on inhibiting the function of lncRNAs by disrupting the interaction between lncRNAs and RBPs with small molecules. NextRNA’s strategy is uniquely differentiated in that it offers optionality to target the lncRNA or the RBP side of the interaction. Our team is driven by a common passion to advance pioneering science that impacts patients. *

	Start	2020-01-01 established
	Industry	small-molecule drug targeting lncRNAs (long non-coding RNAs)
	Industry 2	small-molecule cancer drug
	Person	Verhelle, Dominique (NextRNA Therapeutics 202208– CEO + Co-Founder before CSO before Takeda + Third Rock Ventures)

	Region	Boston, MA
	Country	United States (USA)
	Street	40 Guest Street
	City	02135 Boston, MA
	Tel	+1-617-545-7707
		Address record changed: 2024-08-29

Basic data	Employees	n. a.

		* Document for »About Section«: NextRNA Therapeutics, Inc.. (8/28/24). "Press Release: Bayer and NextRNA Therapeutics Enter Strategic Collaboration to Develop Small Molecules Targeting Long Non-coding RNAs (lncRNAs) in Oncology". Berlin & Boston, MA.

		Record changed: 2024-08-29

More documents for NextRNA Therapeutics Inc.

[1] NextRNA Therapeutics, Inc.. (8/28/24). "Press Release: Bayer and NextRNA Therapeutics Enter Strategic Collaboration to Develop Small Molecules Targeting Long Non-coding RNAs (lncRNAs) in Oncology". Berlin & Boston, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]